Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | GAA | P10253 | 1/20 | 0.71 |
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | POLB | P06746 | 3/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11515850 | 0.87 | GPBAR1 (0.59) | KMT2AMEN1GAATSHRPOLB | |
| SCHEMBL27722453 | 0.86 | KMT2A (0.76) | KMT2AMEN1GAATSHRPOLB | |
| SCHEMBL316093 | 0.86 | KMT2A (0.76) | KMT2AMEN1GAATSHRPOLB | |
| SCHEMBL5708155 | 0.85 | GPBAR1 (0.66) | KMT2AMEN1GAATSHRPOLB | |
| SCHEMBL1574735 | 0.85 | KMT2A (0.73) | KMT2AMEN1GAATSHRPOLB | |
| Hydrochloric Acid SCHEMBL4846563 | 0.85 | KMT2A (0.73) | KMT2AMEN1GAATSHRPOLB | |
| SCHEMBL3068021 | 0.84 | GPBAR1 (0.61) | KMT2AMEN1GAATSHRLMNA | |
| SCHEMBL10929681 | 0.83 | KMT2A (0.71) | KMT2AMEN1GAATSHRPOLB | |
| SCHEMBL903110 | 0.83 | KMT2A (1.00) | KMT2AMEN1GAATSHRPOLB | |
| SCHEMBL7608812 | 0.83 | KMT2A (0.71) | KMT2AMEN1GAATSHRPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118772476-B | High-strength base film for composite current collector and preparation method thereof | 扬州博恒新能源材料科技有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-118772476-A | High-strength base film for composite current collector and preparation method thereof | 扬州博恒新能源材料科技有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-116514839-A | Synthesis method of oxacillin sodium | 国药集团威奇达药业有限公司 | 2023-08-01 | — | — | CN | claimed |
| CN-1233634-C | Chemical synthesis method of 3-phenyl-5-methylisoxazole-4-formyl chloride | UNIV ZHEJIANG POLYTECHNIC (CN) | 2005-12-28 | — | — | CN | claimed |
| CN-1535959-A | Chemical synthesis method of 3-phenyl-5-methylisoxazole-4-formyl chloride | 浙江工业大学 | 2004-10-13 | — | — | CN | claimed |
| EP-0140949-A1 | NOVEL CEPHALOSPORIN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, THEIR USE IN THERAPY AS ANTIBIOTICS AND A PROCESS FOR THE PREPARATION OF THE NOVEL COMPOUNDS | BIOGAL GYOGYSZERGYAR (HU) | 1985-05-15 | — | — | EP | claimed |
| WO-1984004096-A1 | NOVEL CEPHALOSPORIN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, THEIR USE IN THERAPY AS ANTIBIOTICS AND A PROCESS FOR THE PREPARATION OF THE NOVEL COMPOUNDS | BIOGAL GYOGYSZERGYAR (HU) | 1984-10-25 | — | — | WO | claimed |
| CN-121181573-B | Cephalosporium containing C-3 tetrahydrofuran derivative and application thereof | 重庆汉佩生物科技有限公司 | 2026-02-27 | — | — | CN | disclosed |
| CN-116514839-B | Synthesis method of oxacillin sodium | 国药集团威奇达药业有限公司 | 2025-08-12 | — | — | CN | disclosed |
| US-20240425491-A1 | HETEROARYL COMPOUNDS USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS | DRAIG THERAPEUTICS LTD (GB) | 2024-12-26 | — | — | US | disclosed |
| CN-118772476-B | High-strength base film for composite current collector and preparation method thereof | 扬州博恒新能源材料科技有限公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-118772476-B | High-strength base film for composite current collector and preparation method thereof | 扬州博恒新能源材料科技有限公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-118772476-A | High-strength base film for composite current collector and preparation method thereof | 扬州博恒新能源材料科技有限公司 | 2024-10-15 | — | — | CN | disclosed |
| US-4145343-A | BACTERICIDES | UCB SOCIETE ANONYME (BE) | 1979-03-20 | — | — | US | disclosed |
| US-4143039-A | ANTIBACTERIAL 3-(5-TETRAZOLYL)PENAM COMPOUNDS | PFIZER INC. (US) | 1979-03-06 | — | — | US | disclosed |
| US-4139628-A | ANTIBIOTICS | U C B, SOCIETE ANONYME (BE) | 1979-02-13 | — | — | US | disclosed |
| US-4137236-A | ANTIBIOTICS, BACTERICIDES | U C B, SOCIETE ANONYME (BE) | 1979-01-30 | — | — | US | disclosed |
| US-4115385-A | PENICILLINS | PFIZER INC. (US) | 1978-09-19 | — | — | US | disclosed |
| US-4061628-A | Intermediates for producing semi-synthetic penicillins and cephalosporins and methods of production | AMERICAN HOME PRODUCTS CORPORATION (US) | 1977-12-06 | — | — | US | disclosed |
| US-3997532-A | Intermediates for producing semi-synthetic cephalosporins | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240425491-A1 | HETEROARYL COMPOUNDS USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS | GABRA5, GABRB3, GABRA3 | KMT2A 3453/4885MEN1 4676/4885GAA 1976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.